Amgen has made a play in a hot area of immunology R&D, paying $400 million upfront to claim rights to an OX40-targeting drug from Kyowa Kirin that is ready for phase 3 testing for atopic ...

Paraganglioma Global Market Report 2025 - Market Size, Trends, And Global Forecast 2025-2034 The Business Research Company's Global Panuvei ...

Interleukin-23 inhibitors may be able to reduce the risk of developing psoriatic arthritis among patients with psoriasis, ...

The data also keeps Sanofi's drug in contention with other drugs in the class, which include Kyowa Kirin and Amgen's KHK4083, which generated positive results in a phase 2 trial earlier this year ...

We hoped industry layoffs would relent in 2024. That's not what happened. Overall, biopharma layoffs rose 3% last year compared to 2023, according to an analysis of yearly data. So, here we are ...

Killingham's Ryu Ryu no Mi, Model: Kirin is a powerful Devil Fruit revealed in One Piece. Killingham can transform into a Kirin and turn dreams into reality using his Mythical Zoan powers.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...